Trials / Completed
CompletedNCT00586846
Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is designed to test the safety and feasibility of the simultaneous administration of a biphosphonate with chemotherapy for the treatment of osteosarcoma in newly diagnosed patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cisplatin | Cisplatin 120 mg/m\^2 |
| DRUG | Doxorubicin | 75mg/m\^2 |
| DRUG | Methotrexate | Methotrexate 12g/m\^2 |
Timeline
- Start date
- 2003-07-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2008-01-07
- Last updated
- 2016-01-20
- Results posted
- 2016-01-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00586846. Inclusion in this directory is not an endorsement.